Mechanisms of Disease: the role of nerve growth factor in the pathophysiology of bladder disorders
- PMID: 16470209
- DOI: 10.1038/ncpuro0408
Mechanisms of Disease: the role of nerve growth factor in the pathophysiology of bladder disorders
Abstract
The case is compelling for the involvement of nerve growth factor (NGF) in the pathogenesis of lower urinary tract disease, especially in conditions with altered neural function. Remodeling of the micturition pathways occurs following experimental bladder-outlet obstruction, denervation, spinal cord injury, cystitis, and diabetes mellitus. Clinically, NGF levels are elevated in the bladders of men with benign prostatic hyperplasia, women with interstitial cystitis and in patients with idiopathic overactive bladder. Blockade of NGF, using either an endogenous antibody or an antibody against the NGF receptor, prevents neural plasticity and bladder overactivity in experimental models of these conditions. The ability of NGF to trigger bladder overactivity might rely on altering the properties of sodium or potassium channels (or their expression) in bladder afferent fibers. Therapies based on altered NGF levels, or changes in channel properties in afferent nerves, represent an intriguing avenue of investigation for the management of detrusor overactivity or diabetic cystopathy.
Similar articles
-
Nerve growth factor in bladder dysfunction: contributing factor, biomarker, and therapeutic target.Neurourol Urodyn. 2011 Sep;30(7):1227-41. doi: 10.1002/nau.21022. Epub 2011 Apr 21. Neurourol Urodyn. 2011. PMID: 21520250 Review.
-
Mechanisms underlying the recovery of lower urinary tract function following spinal cord injury.Prog Brain Res. 2006;152:59-84. doi: 10.1016/S0079-6123(05)52005-3. Prog Brain Res. 2006. PMID: 16198694 Review.
-
Correlation of urinary nerve growth factor level with pathogenesis of overactive bladder.Neurourol Urodyn. 2008;27(5):417-20. doi: 10.1002/nau.20519. Neurourol Urodyn. 2008. PMID: 17924444
-
Urinary nerve growth factor levels are increased in patients with bladder outlet obstruction with overactive bladder symptoms and reduced after successful medical treatment.Urology. 2008 Jul;72(1):104-8; discussion 108. doi: 10.1016/j.urology.2008.01.069. Epub 2008 Apr 8. Urology. 2008. PMID: 18400272
-
Changes in bladder nerve-growth factor and p75 genetic expression in streptozotocin-induced diabetic rats.BJU Int. 2005 Dec;96(9):1392-6. doi: 10.1111/j.1464-410X.2005.05854.x. BJU Int. 2005. PMID: 16287464
Cited by
-
Molecular Mechanisms of Neurogenic Lower Urinary Tract Dysfunction after Spinal Cord Injury.Int J Mol Sci. 2023 Apr 26;24(9):7885. doi: 10.3390/ijms24097885. Int J Mol Sci. 2023. PMID: 37175592 Free PMC article. Review.
-
Neurogenic Lower Urinary Tract Dysfunction in Spinal Dysraphism: Morphological and Molecular Evidence in Children.Int J Mol Sci. 2023 Feb 12;24(4):3692. doi: 10.3390/ijms24043692. Int J Mol Sci. 2023. PMID: 36835106 Free PMC article. Review.
-
Comparison of the Clinical Efficacy and Adverse Events between Intravesical Injections of Platelet-Rich Plasma and Botulinum Toxin A for the Treatment of Interstitial Cystitis Refractory to Conventional Treatment.Toxins (Basel). 2023 Feb 2;15(2):121. doi: 10.3390/toxins15020121. Toxins (Basel). 2023. PMID: 36828435 Free PMC article.
-
Early Detrusor Application of Botulinum Toxin A Results in Reduced Bladder Hypertrophy and Fibrosis after Spinal Cord Injury in a Rodent Model.Toxins (Basel). 2022 Nov 10;14(11):777. doi: 10.3390/toxins14110777. Toxins (Basel). 2022. PMID: 36356027 Free PMC article.
-
Current Knowledge and Novel Frontiers in Lower Urinary Tract Dysfunction after Spinal Cord Injury: Basic Research Perspectives.Urol Sci. 2022 Jul-Sep;33(3):101-113. doi: 10.4103/uros.uros_31_22. Epub 2022 Aug 25. Urol Sci. 2022. PMID: 36177249 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical